MetLife Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Buy |
32,777
+342
| +1% | +$5.97K | ﹤0.01% | 1611 |
|
|
2025
Q1 | $408K | Sell |
32,435
-651
| -2% | -$8.19K | ﹤0.01% | 1820 |
|
|
2024
Q4 | $349K | Buy |
33,086
+3,769
| +13% | +$39.8K | ﹤0.01% | 1990 |
|
|
2024
Q3 | $425K | Hold |
29,317
| – | – | ﹤0.01% | 1865 |
|
|
2024
Q2 | $249K | Buy |
29,317
+15,533
| +113% | +$132K | ﹤0.01% | 2110 |
|
|
2024
Q1 | $141K | Hold |
13,784
| – | – | ﹤0.01% | 2374 |
|
|
2023
Q4 | $75.5K | Hold |
13,784
| – | – | ﹤0.01% | 2715 |
|
|
2023
Q3 | $52.1K | Hold |
13,784
| – | – | ﹤0.01% | 2825 |
|
|
2023
Q2 | $92.4K | Buy |
+13,784
| New | +$92.4K | ﹤0.01% | 2725 |
|
|
2021
Q4 | – | Sell |
-9,098
| Closed | -$90.8K | – | 2549 |
|
|
2021
Q3 | $90.8K | Buy |
9,098
+3,571
| +65% | +$35.6K | ﹤0.01% | 2478 |
|
|
2021
Q2 | $171K | Hold |
5,527
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q1 | $241K | Buy |
+5,527
| New | +$241K | ﹤0.01% | 1954 |
|